Inovalon
@inovalon.bsky.social
We help healthcare professionals enhance patient care with data-driven insights. A team of content nerds manages this account.
Hear from Inovalon’s quality experts as they unpack the latest CMS Star Ratings results. They’ll share what the data reveals, how health plans have been impacted, and what to do next.
Register now for our live webinar with Quality experts: ow.ly/BvEV50XoLL7
Register now for our live webinar with Quality experts: ow.ly/BvEV50XoLL7
November 10, 2025 at 6:28 PM
Hear from Inovalon’s quality experts as they unpack the latest CMS Star Ratings results. They’ll share what the data reveals, how health plans have been impacted, and what to do next.
Register now for our live webinar with Quality experts: ow.ly/BvEV50XoLL7
Register now for our live webinar with Quality experts: ow.ly/BvEV50XoLL7
Reposted by Inovalon
Thriving in uncertainty: #realworlddata as the foundation for #lifesciences resilience | @inovalon.bsky.social becarispublishing.com/digital-cont...
Thriving in uncertainty: real-world data as the foundation for life sciences resilience | Becaris Publishing
becarispublishing.com
November 3, 2025 at 12:01 PM
Thriving in uncertainty: #realworlddata as the foundation for #lifesciences resilience | @inovalon.bsky.social becarispublishing.com/digital-cont...
Big congrats to our Insights team! At this year’s AMCP Nexus Conference, they earned Gold in the Real-World Evidence category for their study: “Trends in Opioid Use Disorder Diagnoses, Hospitalizations, and Receipt of Treatment in the U.S., 2021–2024.”
October 30, 2025 at 4:22 PM
Big congrats to our Insights team! At this year’s AMCP Nexus Conference, they earned Gold in the Real-World Evidence category for their study: “Trends in Opioid Use Disorder Diagnoses, Hospitalizations, and Receipt of Treatment in the U.S., 2021–2024.”
Inovalon is presenting our latest research at AMCP Nexus 2025, featuring real-world evidence across epilepsy, asthma, opioid abuse, schizophrenia, and more.
Get the insights you need to fuel smarter, faster decision-making: ow.ly/COIL50Xgx3i
Get the insights you need to fuel smarter, faster decision-making: ow.ly/COIL50Xgx3i
October 22, 2025 at 7:38 PM
Inovalon is presenting our latest research at AMCP Nexus 2025, featuring real-world evidence across epilepsy, asthma, opioid abuse, schizophrenia, and more.
Get the insights you need to fuel smarter, faster decision-making: ow.ly/COIL50Xgx3i
Get the insights you need to fuel smarter, faster decision-making: ow.ly/COIL50Xgx3i
Every year, 1.7 million adults in the U.S. develop sepsis; 1 in 3 people who dies in a hospital had sepsis during their stay. With real-time clinical surveillance, we can identify risks earlier, act faster. https://event.on24.com/wcc/r/5082252/14DD467F30055CFD3156A0F631E27D0D
October 20, 2025 at 12:05 PM
Every year, 1.7 million adults in the U.S. develop sepsis; 1 in 3 people who dies in a hospital had sepsis during their stay. With real-time clinical surveillance, we can identify risks earlier, act faster. https://event.on24.com/wcc/r/5082252/14DD467F30055CFD3156A0F631E27D0D
Reposted by Inovalon
WEBINAR: Using real-world data to find the providers who truly shape access and outcomes – October 29, 2025 | Becaris Publishing becarispublishing.com/digital-cont...
WEBINAR: Using real-world data to find the providers who truly shape access and outcomes – October 29, 2025 | Becaris Publishing
becarispublishing.com
October 15, 2025 at 2:34 PM
WEBINAR: Using real-world data to find the providers who truly shape access and outcomes – October 29, 2025 | Becaris Publishing becarispublishing.com/digital-cont...
Higher income usually means higher breast cancer screening rates. Not for women on Medicaid. Discover why in this Data Talks episode. https://ow.ly/TkVj50XaK3p
October 14, 2025 at 11:41 AM
Higher income usually means higher breast cancer screening rates. Not for women on Medicaid. Discover why in this Data Talks episode. https://ow.ly/TkVj50XaK3p
Opioid overdose deaths declined 36.5% from 2023 - 2024. Data shows risk remains high, particularly in the period immediately following hospitalization. Download the white paper here: https://ow.ly/PlFm50X0vCx
October 8, 2025 at 6:40 PM
Opioid overdose deaths declined 36.5% from 2023 - 2024. Data shows risk remains high, particularly in the period immediately following hospitalization. Download the white paper here: https://ow.ly/PlFm50X0vCx
Even after clinics reopened, breast cancer screenings remain stuck at pre-pandemic rates. Women on Medicaid are still missing critical breast cancer screening tests. Download the full study here: https://ow.ly/P5Gj50X71gz
October 6, 2025 at 12:48 PM
Even after clinics reopened, breast cancer screenings remain stuck at pre-pandemic rates. Women on Medicaid are still missing critical breast cancer screening tests. Download the full study here: https://ow.ly/P5Gj50X71gz
Breast cancer screening saves lives. Yet women on Medicaid are screened the least. Why does this disparity persist?
Tune into Data Talks for answers. https://ow.ly/kuNh50X4A6J
Tune into Data Talks for answers. https://ow.ly/kuNh50X4A6J
October 3, 2025 at 3:01 PM
Breast cancer screening saves lives. Yet women on Medicaid are screened the least. Why does this disparity persist?
Tune into Data Talks for answers. https://ow.ly/kuNh50X4A6J
Tune into Data Talks for answers. https://ow.ly/kuNh50X4A6J
Reposted by Inovalon
WEBINAR: Using real-world data to find the providers who truly shape access and outcomes – October 29, 2025 | @inovalon.bsky.social becarispublishing.com/digital-cont...
WEBINAR: Using real-world data to find the providers who truly shape access and outcomes – October 29, 2025 | Becaris Publishing
becarispublishing.com
October 1, 2025 at 2:24 PM
WEBINAR: Using real-world data to find the providers who truly shape access and outcomes – October 29, 2025 | @inovalon.bsky.social becarispublishing.com/digital-cont...
At #NASPAnnual2025, more than 2,000 attendees explored how AI, infusion services, and new operating models are shaping the future of specialty pharmacy. But the most powerful story came from a patient, Taylor John. Here's a recap https://ow.ly/2ziC50X434E
#SpecialtyPharmacy #PharmacistMonth
#SpecialtyPharmacy #PharmacistMonth
October 1, 2025 at 11:55 AM
At #NASPAnnual2025, more than 2,000 attendees explored how AI, infusion services, and new operating models are shaping the future of specialty pharmacy. But the most powerful story came from a patient, Taylor John. Here's a recap https://ow.ly/2ziC50X434E
#SpecialtyPharmacy #PharmacistMonth
#SpecialtyPharmacy #PharmacistMonth
Breast cancer screening saves lives. Yet women on Medicaid are screened the least. Why does this disparity persist?
Tune into Data Talks for answers. www.inovalon.com/resource/bre...
Tune into Data Talks for answers. www.inovalon.com/resource/bre...
Breast Cancer Screening Disparities: Who’s Most at Risk?
In this podcast, find out which groups are missing out on breast cancer screenings and why it matters. Listen now.
www.inovalon.com
September 30, 2025 at 8:08 PM
Breast cancer screening saves lives. Yet women on Medicaid are screened the least. Why does this disparity persist?
Tune into Data Talks for answers. www.inovalon.com/resource/bre...
Tune into Data Talks for answers. www.inovalon.com/resource/bre...
In the news! Inovalon Launches New Data and Analytics Offering on Snowflake AI Data Cloud for Healthcare and Life Sciences
Read more: https://ow.ly/yWY650X3Xoe
Read more: https://ow.ly/yWY650X3Xoe
September 30, 2025 at 12:10 PM
In the news! Inovalon Launches New Data and Analytics Offering on Snowflake AI Data Cloud for Healthcare and Life Sciences
Read more: https://ow.ly/yWY650X3Xoe
Read more: https://ow.ly/yWY650X3Xoe
Significant updates to the MDS 3.0 Item Sets and RAI Manual take effect Oct. 1, 2025. Is your team prepared?
From revised item sets to new reporting requirements, compliance will take more effort.
From revised item sets to new reporting requirements, compliance will take more effort.
www.cms.gov
September 24, 2025 at 12:05 PM
Significant updates to the MDS 3.0 Item Sets and RAI Manual take effect Oct. 1, 2025. Is your team prepared?
From revised item sets to new reporting requirements, compliance will take more effort.
From revised item sets to new reporting requirements, compliance will take more effort.
Opioid overdoses fell 36.5% in 2024. But, OUD remains a costly public health challenge. Our new study breaks down hospitalizations & treatment access by insurance type, age, sex & state.
www.inovalon.com/resource/tre...
www.inovalon.com/resource/tre...
September 19, 2025 at 2:23 PM
Opioid overdoses fell 36.5% in 2024. But, OUD remains a costly public health challenge. Our new study breaks down hospitalizations & treatment access by insurance type, age, sex & state.
www.inovalon.com/resource/tre...
www.inovalon.com/resource/tre...
Trends in Opioid Use Disorder Diagnoses, Hospitalizations, and Receipt of Treatment in the U.S., 2021-2024 www.inovalon.com/resource/tre...
September 19, 2025 at 1:46 AM
Trends in Opioid Use Disorder Diagnoses, Hospitalizations, and Receipt of Treatment in the U.S., 2021-2024 www.inovalon.com/resource/tre...
Join technology and healthcare leaders for forward-thinking insights, meaningful connections, and actionable strategies to streamline your day-to-day operations.
Register today for #InovalonEmpower25 and invite a colleague. Every paid registrant receives a complimentary pass: ow.ly/emFT50WVry7
Register today for #InovalonEmpower25 and invite a colleague. Every paid registrant receives a complimentary pass: ow.ly/emFT50WVry7
September 11, 2025 at 8:10 PM
Join technology and healthcare leaders for forward-thinking insights, meaningful connections, and actionable strategies to streamline your day-to-day operations.
Register today for #InovalonEmpower25 and invite a colleague. Every paid registrant receives a complimentary pass: ow.ly/emFT50WVry7
Register today for #InovalonEmpower25 and invite a colleague. Every paid registrant receives a complimentary pass: ow.ly/emFT50WVry7
Reposted by Inovalon
WEBINAR: Finding the providers who truly shape access and outcomes – October 29, 2025 | @inovalon.bsky.social becarispublishing.com/digital-cont...
WEBINAR: Finding the providers who truly shape access and outcomes – October 29, 2025 | Becaris Publishing
becarispublishing.com
September 10, 2025 at 11:02 AM
WEBINAR: Finding the providers who truly shape access and outcomes – October 29, 2025 | @inovalon.bsky.social becarispublishing.com/digital-cont...
80% of healthcare data goes unused.
Learn how to unlock the 20% that drives impact across studies, strategy, and regulatory decisions.
Experts Sara Pesko and Eric Barrette share ways to evaluate and apply RWD with purpose.
Secure your spot today: ow.ly/Ugx650WU0uz
Learn how to unlock the 20% that drives impact across studies, strategy, and regulatory decisions.
Experts Sara Pesko and Eric Barrette share ways to evaluate and apply RWD with purpose.
Secure your spot today: ow.ly/Ugx650WU0uz
September 9, 2025 at 4:21 PM
80% of healthcare data goes unused.
Learn how to unlock the 20% that drives impact across studies, strategy, and regulatory decisions.
Experts Sara Pesko and Eric Barrette share ways to evaluate and apply RWD with purpose.
Secure your spot today: ow.ly/Ugx650WU0uz
Learn how to unlock the 20% that drives impact across studies, strategy, and regulatory decisions.
Experts Sara Pesko and Eric Barrette share ways to evaluate and apply RWD with purpose.
Secure your spot today: ow.ly/Ugx650WU0uz
Prior authorization delays care. Clinicians spend countless hours on paperwork instead of patients. Inovalon’s partnership with Google Cloud is tackling this head-on with AI-enabled solutions to restore balance. ow.ly/o4Az50WMbuU
Google Cloud And Inovalon Ink Deal To Build Prior Authorization Agentic AI System
The prior authorization process is one of the most time-consuming aspects of the clinical workflow.
ow.ly
September 4, 2025 at 3:59 PM
Prior authorization delays care. Clinicians spend countless hours on paperwork instead of patients. Inovalon’s partnership with Google Cloud is tackling this head-on with AI-enabled solutions to restore balance. ow.ly/o4Az50WMbuU
Our ISPOR 2025 posters reveal striking real-world patterns, like lower breast cancer screening rates among Medicaid-insured women and a 50% discontinuation rate for antifibrotics in IPF patients.
Here's an overview by Christie Teigland.
Here's an overview by Christie Teigland.
ISPOR 2025 Poster Presentations Highlight Real-World Evidence
Discover insights from Inovalon’s nine ISPOR 2025 poster presentations, highlighting how real-world evidence drives better care.
www.inovalon.com
September 3, 2025 at 5:35 PM
Our ISPOR 2025 posters reveal striking real-world patterns, like lower breast cancer screening rates among Medicaid-insured women and a 50% discontinuation rate for antifibrotics in IPF patients.
Here's an overview by Christie Teigland.
Here's an overview by Christie Teigland.
We're excited to announce our collaboration with Google Cloud to address administrative burden in healthcare
Read more: ow.ly/WYcp50WLETk
Read more: ow.ly/WYcp50WLETk
August 27, 2025 at 4:31 PM
We're excited to announce our collaboration with Google Cloud to address administrative burden in healthcare
Read more: ow.ly/WYcp50WLETk
Read more: ow.ly/WYcp50WLETk
With an opioid crisis that continues to evolve, healthcare providers need more than static alerts to protect at-risk patients. Learn how near real-time clinical surveillance transforms raw EHR data into actionable intelligence. Register here: ow.ly/t1IB50WHaMZ
August 19, 2025 at 3:01 PM
With an opioid crisis that continues to evolve, healthcare providers need more than static alerts to protect at-risk patients. Learn how near real-time clinical surveillance transforms raw EHR data into actionable intelligence. Register here: ow.ly/t1IB50WHaMZ
1 in 4 adults live with chronic pain. We know more about it than ever. Why aren't patients getting better?
Inovalon’s Dr. Olufunke Pickering joined leading experts to discuss why. www.newsweek.com/2025/08/22/c... via @newsweek.com
Inovalon’s Dr. Olufunke Pickering joined leading experts to discuss why. www.newsweek.com/2025/08/22/c... via @newsweek.com
Chronic pain science has advanced. Why are treatments stuck in the past?
Science had its 'chronic Pain revolution.' So why is treatment still broken, delayed and out of reach?
www.newsweek.com
August 12, 2025 at 2:59 PM
1 in 4 adults live with chronic pain. We know more about it than ever. Why aren't patients getting better?
Inovalon’s Dr. Olufunke Pickering joined leading experts to discuss why. www.newsweek.com/2025/08/22/c... via @newsweek.com
Inovalon’s Dr. Olufunke Pickering joined leading experts to discuss why. www.newsweek.com/2025/08/22/c... via @newsweek.com